FIL Limited增持医脉通271.55万股 每股作价约9.63港元

Core Viewpoint - FIL Limited has increased its stake in the company 医脉通 (02192) by acquiring 2.7155 million shares at a price of HKD 9.6301 per share, totaling approximately HKD 26.1505 million, resulting in a new holding of about 37.1726 million shares, representing 5.04% ownership [1] Group 1 - FIL Limited's acquisition of shares indicates a strategic investment in 医脉通, reflecting confidence in the company's future prospects [1] - The transaction involved related parties, specifically Pandanus Associates Inc. and Pandanus Partners L.P., suggesting potential collaborative interests or shared investment strategies [1] - The increase in shareholding percentage to 5.04% may influence market perception and investor sentiment towards 医脉通 [1]